-+ 0.00%
-+ 0.00%
-+ 0.00%

Benitec Biopharma Q3 EPS $(0.24) Beats $(0.27) Estimate

Benzinga·05/14/2026 12:41:57
Listen to the news
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.27) by 11.11 percent. This is a 36.84 percent increase over losses of $(0.38) per share from the same period last year.